Abstract-Posttranslational modification of target substrates underlies biological processes through activation/inactivation of signaling cascades. To concurrently identify the phosphoprotein substrates associated with cardiac -adrenergic signaling, the mouse myocyte phosphoproteome was analyzed using 2-D gel electrophoresis in combination with 32 P autoradiography. Phosphoprotein spots, detected by silver staining, were identified using MALDI-TOF mass spectrometry in conjunction with computer-assisted protein spot matching. Stimulation with isoproterenol (1 mol/L for 5 minutes) was associated with maximal increases in myocyte contractile parameters, and significant stimulation of the phosphorylation of troponin I (190Ϯ23%) and succinyl CoA synthetase (160Ϯ16%), whereas the phosphorylation of pyruvate dehydrogenase (48Ϯ10%), NADH-ubiquinone oxidoreductase (46Ϯ6%), heat shock protein 27 (18Ϯ3%), ␣B-crystallin (20Ϯ3%), and an unidentified 26-kDa protein (29Ϯ7%) was significantly decreased, compared with unstimulated cells (100%). After sustained (30 minutes) stimulation with isoproterenol, only the alterations in the phosphorylation levels of troponin I and NADH-ubiquinone oxidoreductase were maintained and de novo phosphorylation of a phosphoprotein (Ϸ20 kDa and pI 5.5) was observed. The tryptic peptide fragments of this phosphoprotein were sequenced using postsource decay mass spectrometry, and the protein was subsequently cloned and designated as p20, based on its high sequence homology with rat and human skeletal p20. The mouse cardiac p20 contains the conserved domain sequences for heat shock proteins, and the RRAS consensus sequence for cAMP-PKA substrates. LC-MS/MS phosphorylation mapping confirmed phosphorylation of Ser 16 in p20 on -agonist stimulation. Adenoviral gene transfer of p20 was associated with significant increases in contractility and Ca transient peak in adult rat cardiomyocytes, suggesting an important role of p20 in cardiac function. These findings suggest that cardiomyocytes undergo significant posttranslational modification via phosphorylation in a multitude of proteins to dynamically fine-tune cardiac responses to -adrenergic signaling.
-Adrenergic receptors and their signaling effectors are key mediators of neurohormonal influence over the cardiovascular system, modulating the strength, velocity, and frequency of cardiac contraction and relaxation. 1 At the subcellular level, the cardiac responses to -adrenergic agonists are associated with phosphorylation of several downstream target phosphoproteins. Multiple studies have indicated that the most critical substrates for the positive inotropic and lusitropic -agonist effects are phospholamban in the sarcoplasmic reticulum (SR) and troponin I (TnI) in the myofilaments, both phosphorylated through the cAMPdependent protein kinase A (PKA) pathway. 2-4 Phosphorylation of phospholamban relieves its inhibitory effects on SERCA2, with subsequent acceleration of SR Ca 2ϩ transport, and phosphorylation of TnI reduces the myofilament sensiti...